Acadia Healthcare's (ACHC) Outperform Rating Reaffirmed at Royal Bank of Canada

Acadia Healthcare (NASDAQ:ACHC - Get Free Report)'s stock had its "outperform" rating reaffirmed by equities research analysts at Royal Bank of Canada in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $64.00 price target on the stock. Royal Bank of Canada's target price points to a potential upside of 42.48% from the company's previous close.

Other analysts have also recently issued research reports about the stock. KeyCorp raised shares of Acadia Healthcare from a "sector weight" rating to an "overweight" rating and set a $70.00 target price on the stock in a research note on Tuesday. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and increased their target price for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. StockNews.com cut shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday. Barclays cut their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research report on Friday, November 22nd. Finally, Cantor Fitzgerald reissued a "neutral" rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $70.22.

Acadia Healthcare Stock Performance

Shares of ACHC traded down $0.20 during midday trading on Friday, reaching $44.92. 1,930,656 shares of the stock were exchanged, compared to its average volume of 2,303,759. The stock's 50 day simple moving average is $40.48 and its 200 day simple moving average is $58.19. The company has a market cap of $4.17 billion, a P/E ratio of 14.73, a PEG ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.91 EPS. On average, sell-side analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ACHC. GAMMA Investing LLC grew its holdings in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after acquiring an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in Acadia Healthcare in the 2nd quarter worth about $59,000. Covestor Ltd boosted its position in shares of Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after acquiring an additional 1,018 shares during the last quarter. DekaBank Deutsche Girozentrale bought a new position in shares of Acadia Healthcare in the third quarter worth approximately $86,000. Finally, Assetmark Inc. raised its stake in Acadia Healthcare by 66.1% in the third quarter. Assetmark Inc. now owns 1,485 shares of the company's stock valued at $94,000 after purchasing an additional 591 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.